000 01471 a2200385 4500
005 20250516051926.0
264 0 _c20111115
008 201111s 0 0 eng d
022 _a1744-2818
024 7 _a10.3109/13506129.2011.574354055
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCoriu, D
245 0 0 _aBortezomib in systemic AL amyloidosis: a single center experience.
_h[electronic resource]
260 _bAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
_cJun 2011
300 _a148-50 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAmyloidosis
_xdrug therapy
650 0 4 _aBoronic Acids
_xtherapeutic use
650 0 4 _aBortezomib
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Light Chains
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPyrazines
_xtherapeutic use
700 1 _aBadelita, S
700 1 _aTalmaci, R
700 1 _aDobrea, C
700 1 _aDogaru, M
700 1 _aOstroveanu, D
700 1 _aCrisan, M
773 0 _tAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
_gvol. 18 Suppl 1
_gp. 148-50
856 4 0 _uhttps://doi.org/10.3109/13506129.2011.574354055
_zAvailable from publisher's website
999 _c21082699
_d21082699